Literature DB >> 19962262

Software-based quantification of contrast-enhanced ultrasound in focal liver lesions--a feasibility study.

Ruediger S Goertz1, Thomas Bernatik, Deike Strobel, Eckhart G Hahn, Thomas Haendl.   

Abstract

PURPOSE: To compare software-based quantification of contrast-enhanced ultrasound (CEUS) examinations of focal liver lesions in the arterial and late phases with the enhancement patterns established by the sonologist.
MATERIALS AND METHODS: The study cohort comprised 12 malignant and 21 benign hepatic lesions in 33 patients (18 female and 15 male; aged 57 +/- 13 years). All underwent dynamic real-time low mechanical index (<0.3) CEUS, which was stored as video sequences of the various enhancement phases. A software was used for analysis by using different regions of interest (ROI) in a double-blinded manner. The software generated and the visual enhancement patterns were compared, and the t-test was performed.
RESULTS: The videos containing the arterial phase had a mean length of 37.5 +/- 36.7 s and the late phase sequences a mean length of 15.2 +/- 9.2 s. In the arterial phase complete agreement between software and sonologist was 100%, 93.9% and 87.9% with regard to the entire lesion, its centre and its periphery, respectively. The late phase analysis revealed corresponding figures of 90.9%, 87.9% and 90.9%. In the late phase, benign lesions revealed a mean relative enhancement of +65.1 +/- 103.6% and malignant lesions -56.9 +/- 26.3% (p=0.0005) vis-à-vis liver parenchyma. All the malignant and 14% of the benign tumors showed hypo-enhancement of less than -10%.
CONCLUSION: The complete agreement between the quantitative analysis and the sonologist within the arterial and late phase showed excellent results. Software analysis of the late phase could dichotomise benign and malignant lesions. Objective establishment of iso-enhancement in the late phase excludes malignancy. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962262     DOI: 10.1016/j.ejrad.2009.11.004

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Comparison of superb microvascular imaging (SMI) quantified with ImageJ to quantified contrast-enhanced ultrasound (qCEUS) in liver metastases-a pilot study.

Authors:  Wolfgang Kratzer; Melanie Güthle; Felix Dobler; Thomas Seufferlein; Tilmann Graeter; Julian Schmidberger; Thomas Fe Barth; Jochen Klaus
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors.

Authors:  Costin Teodor Streba; Mihaela Ionescu; Dan Ionut Gheonea; Larisa Sandulescu; Tudorel Ciurea; Adrian Saftoiu; Cristin Constantin Vere; Ion Rogoveanu
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

3.  Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.

Authors:  X-Q Pei; L-Z Liu; Y-H Xiong; R-H Zou; M-S Chen; A-H Li; M-Y Cai
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

4.  Qualitative and quantitative analysis with contrast-enhanced ultrasonography: diagnosis value in hypoechoic renal angiomyolipoma.

Authors:  Qing Lu; Bei-jian Huang; Wen-ping Wang; Cui-xian Li; Li-yun Xue
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

5.  Focal Lesions in Fatty Liver: If Quantitative Analysis Facilitates the Differentiation of Atypical Benign from Malignant Lesions.

Authors:  Quan-Yuan Shan; Li-Da Chen; Lu-Yao Zhou; Zhu Wang; Guang-Jian Liu; Yang Huang; Wei Li; Jin-Ya Liu; Xiao-Yan Xie; Ming-de Lu; Jie Liu; Wei Wang
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.